Chemotherapy + Immune checkpoint inhibitor Clinical Trials

1 actively recruiting trial

Also known as: Pembrolizumab

Top Sponsors

Universitaire Ziekenhuizen KU Leuven1

Indications

Lung Diseases, Interstitial1
Immunotherapy1
NSCLC1
Lung Cancer1
Cancer1

Other1 trial

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.